The information contained in this portal is strictly confidential and is being provided solely for the purpose of evaluating a potential investment in Dox Health.
By accessing this portal, you agree to:
1. Keep all information strictly confidential and not disclose it to any third party without prior written consent from Dox Health.
2. Use this information solely for evaluating a potential investment in Dox Health.
3. Not copy, reproduce, or distribute any part of this information in any form.
4. Return or destroy all materials upon request by Dox Health.
5. Acknowledge that this information may include forward-looking statements and that past performance does not guarantee future results.
This agreement is governed by the laws of the Commonwealth of Massachusetts.
D
DOX HEALTH
Investor Preview
CONFIDENTIAL
DOX HEALTH
Designed for Optimal X, your health outcome. Quantitatively PERsonalized (QPER) health platform for optimal outcomes.
Founded
2019
Current round
FF5
$30/share
Total raised
$528K+
from investors
Valuation
$31.3M
pre-money FF5
Authorized shares
3,000,000
Issued shares
1,045,275
34.8% of authorized
Available shares
1,954,725
65.2% remaining
Key metrics
Total investors
27
Friends & Family rounds
Rounds completed
FF1–FF5
2020 → 2026
Share price growth
4.3x
$7 → $30/share
Current price
$30
FF5 price/share
Product & company milestones
FF1
$7/share
Friends & Family 1 — Jan 2020
Pre-money valuation $7.00M
Exercise + calories mapped to fasting blood glucose
Small pilot study completed to validate prediction algorithm
FF2
$9.80/share
Friends & Family 2 — Nov 2021
Pre-money valuation $10.03M↑ 1.43× from FF1
Exercise & calorie balance tracking implemented
Apple Watch + weight scale integration working
Preliminary version of app UI delivered
FF3
$13.60/share
Friends & Family 3 — May 2022
Pre-money valuation $14.03M↑ 1.40× from FF2
Blood pressure + blood glucose monitor integration working
Health Journey concept with baseline & transformation implemented
Preliminary version of full platform delivered
FF4
$24/share
Friends & Family 4 — 2024
Pre-money valuation $24.88M↑ 1.77× from FF3
Intentional movement + mindful nutrition + Health Age introduced
Full device integration with input/output approach
Final UI + Health Map + Digital Twin completed
🎉 QPER Health App approved on Apple App Store — April 25, 2024
⚙️ Internal testing environment — Time Machine — completed
FF5
$30/share
Friends & Family 5 — 2026
Pre-money valuation $31.32M↑ 1.26× from FF4
🏆 CIC Social Impact Growth Cohort Accelerator program
🔬 Patent granted for Health Map — our fundamental technology
🤝 Agreement with Prism Benefits serving 1,900+ small-mid size employers in New England — 20,000+ total members
🚀 First employer onboarded — sponsoring QPER Health for their employees
🔄 Technical flow upgraded from D2C to D2C + B2B model
🏢 Employer portal completed
Pre-money valuation = shares outstanding before each round × that round's price per share. Valuation grew 4.5× from FF1 to FF5.
Valuation growth (pre-money)
Cap table summary — anonymized
Investor names are anonymized for privacy
Investor
Rounds
Shares
Value @ $30
Return
What if calculator
What if you had invested at FF1?
See how much your investment would be worth today at the original $7/share price